Clinical Data Kainova expands DT 7012 trial into Europe PharmaTimesFirst patient dosed as DOMISOL study grows beyond AustraliaClinical DataOncologyRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) PharmaTimes First patient dosed as DOMISOL study grows beyond Australia Clinical DataOncologyRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Roche sticks with C4T, adding up to $1B for molecular glue partnershipNext: Innovent’s CDMO gets green light to make biologics at large Chinese plant Related Stories Clinical Data Parsortix study shows promise for ADC target detection pharminent August 3, 2026 Clinical Data Novo setback casts doubt on a new way to treat heart disease pharminent July 31, 2026 Clinical Data Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study pharminent July 28, 2026
